» Articles » PMID: 32887641

TRNA-derived RNA Fragments in Cancer: Current Status and Future Perspectives

Overview
Journal J Hematol Oncol
Publisher Biomed Central
Specialties Hematology
Oncology
Date 2020 Sep 5
PMID 32887641
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Non-coding RNAs (ncRNAs) have been the focus of many studies over the last few decades, and their fundamental roles in human diseases have been well established. Transfer RNAs (tRNAs) are housekeeping ncRNAs that deliver amino acids to ribosomes during protein biosynthesis. tRNA fragments (tRFs) are a novel class of small ncRNAs produced through enzymatic cleavage of tRNAs and have been shown to play key regulatory roles similar to microRNAs. Development and application of high-throughput sequencing technologies has provided accumulating evidence of dysregulated tRFs in cancer. Aberrant expression of tRFs has been found to participate in cell proliferation, invasive metastasis, and progression in several human malignancies. These newly identified functional tRFs also have great potential as new biomarkers and therapeutic targets for cancer treatment. In this review, we focus on the major biological functions of tRFs including RNA silencing, translation regulation, and epigenetic regulation; summarize recent research on the roles of tRFs in different types of cancer; and discuss the potential of using tRFs as clinical biomarkers for cancer diagnosis and prognosis and as therapeutic targets for cancer treatment.

Citing Articles

A novel 5'tRNA-derived fragment tRF-Tyr inhibits tumor progression by targeting hnRNPD in gastric cancer.

Cui H, Liu Z, Peng L, Liu L, Xie X, Zhang Y Cell Commun Signal. 2025; 23(1):88.

PMID: 39953522 PMC: 11829405. DOI: 10.1186/s12964-025-02086-2.


The role of tRNA-Derived small RNAs (tsRNAs) in pancreatic cancer and acute pancreatitis.

Pan Y, Ying X, Zhang X, Jiang H, Yan J, Duan S Noncoding RNA Res. 2025; 11:200-208.

PMID: 39896345 PMC: 11786804. DOI: 10.1016/j.ncrna.2024.12.011.


Diagnostic and Therapeutic Advances of RNAs in Precision Medicine of Gastrointestinal Tumors.

Liu R, Zhou J, Chen X, Zhang J, Chen Q, Liu X Biomedicines. 2025; 13(1).

PMID: 39857631 PMC: 11762367. DOI: 10.3390/biomedicines13010047.


tRNA-derived small RNAs: their role in the mechanisms, biomarkers, and therapeutic strategies of colorectal cancer.

Zhang B, Pan Y, Li Z, Hu K J Transl Med. 2025; 23(1):51.

PMID: 39806419 PMC: 11727791. DOI: 10.1186/s12967-025-06109-x.


tRNA-derived small RNAs in disease immunity.

Jia H, Zhang L Theranostics. 2025; 15(1):245-257.

PMID: 39744232 PMC: 11667222. DOI: 10.7150/thno.102650.


References
1.
Dhahbi J, Spindler S, Atamna H, Yamakawa A, Boffelli D, Mote P . 5' tRNA halves are present as abundant complexes in serum, concentrated in blood cells, and modulated by aging and calorie restriction. BMC Genomics. 2013; 14:298. PMC: 3654920. DOI: 10.1186/1471-2164-14-298. View

2.
Cui Y, Huang Y, Wu X, Zheng M, Xia Y, Fu Z . Hypoxia-induced tRNA-derived fragments, novel regulatory factor for doxorubicin resistance in triple-negative breast cancer. J Cell Physiol. 2018; 234(6):8740-8751. DOI: 10.1002/jcp.27533. View

3.
Wang X, Cai X, Xiong W, Liu Y, Li C, Liu Q . Identification of tRNA‑derived fragments in colon cancer by comprehensive small RNA sequencing. Oncol Rep. 2019; 42(2):735-744. DOI: 10.3892/or.2019.7178. View

4.
Torres A, Reina O, Stephan-Otto Attolini C, Ribas de Pouplana L . Differential expression of human tRNA genes drives the abundance of tRNA-derived fragments. Proc Natl Acad Sci U S A. 2019; 116(17):8451-8456. PMC: 6486751. DOI: 10.1073/pnas.1821120116. View

5.
Telonis A, Rigoutsos I . Race Disparities in the Contribution of miRNA Isoforms and tRNA-Derived Fragments to Triple-Negative Breast Cancer. Cancer Res. 2017; 78(5):1140-1154. PMC: 5935570. DOI: 10.1158/0008-5472.CAN-17-1947. View